Fifth Third Bancorp »

Corvus Pharmaceuticals shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $306 21 14.62

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Vanguard Capital Management
Vivo Capital
State Street Corporation
Morgan Stanley
Deep Track Capital
Perceptive Advisors
Commodore Capital
Foresite Capital Management VI
Braidwell
Geode Capital Management
MPM Oncology Impact Management

View all funds holding Corvus Pharmaceuticals